Cynosure Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Cynosure Management, LLC
- $854 Million
- Q2 2025
A detailed history of Cynosure Management, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Cynosure Management, LLC holds 17,820 shares of AMPH stock, worth $418,948. This represents 0.05% of its overall portfolio holdings.
Number of Shares
17,820
Previous 12,401
43.7%
Holding current value
$418,948
Previous $359,000
13.93%
% of portfolio
0.05%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding AMPH
# of Institutions
256Shares Held
33.3MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$140 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$63.2 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$47.8 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$38.2 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$37.1 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.15B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...